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Abstract
We introduce a general, flexible, parametric survival modelling framework
which encompasses key shapes of hazard function (constant, increasing, decreas-
ing, up-then-down, down-then-up), various common survival distributions (log-
logistic, Burr type XII, Weibull, Gompertz), and includes defective distributions
(i.e., cure models). This generality is achieved using four basic distributional
parameters: two scale-type parameters and two shape parameters. Generalising
to covariate dependence, the scale-type regression components correspond to
accelerated failure time (AFT) and proportional hazards (PH) models. There-
fore, this general formulation unifies the most popular survival models which
allows us to consider the practical value of possible modelling choices for sur-
vival data. Furthermore, in line with our proposed flexible baseline distribution,
we advocate the use of multi-parameter regression in which more than one dis-
tributional parameter depends on covariates – rather than the usual convention
of having a single covariate-dependent (scale) parameter. While many choices
are available, we suggest introducing covariates through just one or other of the
two scale parameters, which covers AFT and PH models, in combination with
a “power” shape parameter, which allows for more complex non-AFT/non-PH
effects, while the other shape parameter remains covariate-independent, and
handles automatic selection of the baseline distribution. We explore inferential
issues in simulations, both with and without a covariate, with particular focus
on evidence concerning the need, or otherwise, to include both AFT and PH
parameters. We illustrate the efficacy of our modelling framework by inves-
tigating differences between treatment groups using data from a lung cancer
study and a melanoma study. Censoring is accommodated throughout.
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1 Introduction
This article is concerned with both theoretical and practical aspects of parametric
survival analysis with a view to providing an attractive and flexible general modelling
approach to analysing survival data in areas such as medicine, population health,
and disease modelling. In particular, focus will be on the choice of an appropriate
flexible form for the distribution of the survival outcome and the efficient use of
multi-parameter regression to understand the effects of covariates on survival.
We consider a univariate lifetime random variable, T > 0, the primary survival
outcome, whose cumulative hazard function (c.h.f.), H(t), is, atypically perhaps,
modelled using a flexible parametric form which we take to be
H(t) = λH0 ((φt)
γ ; κ) , t > 0. (1)
Here, H0(·; κ) is an underlying c.h.f. with shape parameter κ, and φ > 0, λ > 0 and
γ > 0 are further parameters with the following distinct interpretations: φ controls the
horizontal scaling of the hazard function, and is well known as the accelerated failure
time parameter (also, 1/φ is the usual distributional scale parameter); λ controls the
vertical scaling of the hazard function, and is well known as the proportional hazards
parameter; and γ is a second shape parameter which is explicitly defined as a power
parameter (unlike κ which can enter in potentially more complicated ways, and might
even represent a vector of parameters). Were Y = log(T ) to be modelled as a location-
scale distribution on R, then µ = − log φ and σ = 1/γ would be the location and scale
of that distribution, respectively, these relationships driving our preference to specify
γ as a power parameter rather than as a more general shape parameter. As will be
clear in the sequel, we intend that only one of the scale parameters be present in the
model in order to avoid identifiability issues (i.e., we fix λ = 1 or φ = 1). However,
we write the model in a general way for the purpose of unification of sub-models.
In this article, we also propose a specific choice for H0(t
γ ; κ), namely
HA(t; γ, κ) =
κ+ 1
κ
{(
1 +
tγ
κ+ 1
)κ
− 1
}
, t > 0. (2)
corresponding to an adapted form of the ‘power generalised Weibull’ (PGW) distri-
bution introduced by Bagdonavic¸ius and Nikulin (2002); we will use APGW to stand
for ‘adapted PGW’. This choice has some major advantages: with just two shape
parameters, the full range of simplest hazard shapes, namely, constant, increasing,
decreasing, up-then-down or down-then-up (and no others), are available, the param-
eters γ and κ controlling this through the way they control behaviour of the hazard
2
function near zero and at infinity. Here, we use the simple descriptive terms ‘up-then-
down’ and ‘down-then-up’ to avoid the term ‘bathtub-shaped’, which is down-then-up
but with a flat valley, the clumsy term ‘upside-down-bathtub-shaped’, and the terms
‘unimodal/uniantimodal’ which also encompass monotone hazards. Our adaptation
of the PGW distribution also allows κ to control distributional choice within the
family: for κ ≥ 0, log-logistic and Burr Type XII distributions are the heaviest
tailed members, Weibull distributions (κ = 1) are ‘central’ within the family, and
Gompertz-related distributions are the most lightly tailed. See Section 2 for details
of this model, which also include its cure model special cases when −1 < κ < 0.
Any one or more of the four distributional parameters in model (1) can be made to
depend, typically log-linearly, on covariates; such “multi-parameter regression” is one
of the focusses of this work. Indeed, this general formulation covers the most popular
survival models, e.g., the accelerated failure time (AFT) model when φ depends on
covariates, the proportional hazards (PH) model when λ depends on covariates, and
semi-parametric versions when H0 is an unspecified function. In particular, an ad-
vantage of considering (1) is that one may evaluate the breadth of possible modelling
choices. Our primary focus in this respect is to consider which distributional param-
eters should depend on covariates to assess, for example, whether an AFT model (φ
regression) is, in general, likely to provide a superior fit when compared with a PH
model (λ regression), the utility of a simultaneous AFT-PH model (simultaneous φ
and λ regression components; Chen and Jewell (2001)) when κ 6= 1, and the merits
of a shape regression component (γ or κ) in addition to the, more standard, AFT
and PH components. One might also consider whether or not non-parametric com-
ponents should be introduced either for functions of covariates within the regression
equations, or for the baseline c.h.f., H0, or both. However, this is beyond the scope
of the current paper.
The reason for our focus on the core model structure rather than the development
of non-/semi-parametric approaches is that, within the survival literature, there is
a general over-emphasis placed on semi-parametric models – compared with other
fields of statistics – to the extent that many useful parametric alternatives do not
receive the attention they deserve. In particular, practitioners are often content with
the “flexibility” afforded by a non-parametric baseline function without concerning
themselves with the possibly inflexible structural assumptions of the model at hand.
Indeed, a structurally flexible parametric framework has the potential to outperform
a less flexible semi-parametric model; for example, there might be more to be gained
by contemplating the extension of a PH model (λ regression) to include a γ shape
regression, than by extension to a non-parametric H0. Of course, this is not to
downplay the importance of a sufficiently flexible baseline function, and our proposed
choice for H0, (2), is quite general as it covers a wide variety of popular survival
distributions.
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After Section 2, in which we justify our choice of baseline distribution and develop
its properties, we consider the extension to regression modelling in Section 3, including
model interpretation and estimation. Then, the properties of estimation within this
general framework, and further practical aspects, are explored using simulated and
real data in Sections 4 and 5, respectively. Finally, we close with some discussion in
Section 6.
2 The Specific Model for H0
2.1 Basic Definition and Properties
We recommend for general use the APGW distribution with c.h.f. given by (2) and
hazard function is
hA(t; γ, κ) = γt
γ−1
(
1 +
tγ
κ+ 1
)κ−1
, t > 0. (3)
This is a tractable distribution with readily available formulae for its (unimodal) den-
sity, survivor and quantile functions also. It comes about by a particular vertical and
horizontal rescaling of the original PGW distribution which has c.h.f. HN(t; γ, κ) =
(1 + tγ)κ − 1 (see Bagdonavic¸ius and Nikulin (2002), Nikulin and Haghighi (2009)
and Dimitrakopoulou et al. (2007); the γ = 1 special case of HN is the extended
exponential distribution of Nadarajah and Haghighi (2011)). This resulting APGW
distribution then retains attractive shape properties of the PGW distribution’s haz-
ard function, includes important survival distributions as special and limiting cases
and extends to cure models, as we now show.
First, for fixed γ, κ > 0,
hA(t; γ, κ) ∼ γ t
γ−1 as t→ 0 and hA(t; γ, κ) ∼ (κ+ 1)
1−κγ tκγ−1 as t→∞.
The power parameter γ controls the behaviour of the hazard function at zero: it
goes to 0 (constant)∞ as γ > (=) < 1. As t → ∞, the hazard function goes to
0 (constant)∞ as κγ < (=) > 1. In fact, the APGW hazard function joins these tails
smoothly in such a way that its hazard shapes are readily shown to be as listed in
Table 1. Whenever the hazard function is non-monotone, its mode/antimode is at
{(1− γ)(κ+ 1)/(κγ − 1)}1/γ .
Defining HA by (2) allows us to identify an especially large number of special and
limiting cases, many important and well known, some less so, as listed in Table 2.
(For the ‘Weibull extension’ distribution, see Chen (2000) and Xie et al. (2002).) The
shapes of their hazard functions, which are also given in Table 2, reflect the general
shape properties of Table 1, of course.
4
Table 1: Shapes of PGW hazard functions
γ κγ shape
1 1 constant
≤ 1 ≤ 1 decreasing
≤ 1 ≥ 1 down-then-up
≥ 1 ≤ 1 up-then-down
≥ 1 ≥ 1 increasing
Here, pairs of ≤’s and/or ≥’s
include the convention ‘and
not both equal at once’.
Table 2: Special and limiting cases of APGW distributions
κ HA shapes of hA distribution others encompassed
0 log(1 + tγ) decreasing, log-logistic HA × λ⇒ Burr type XII
up-then-down
1 tγ decreasing, Weibull γ = 1⇒ exponential
constant,
increasing
2 tγ + 1
6
t2γ decreasing, γ = 1⇒ linear hazard
down-then-up,
increasing
∞ et
γ
− 1 increasing, HA × λ⇒ Weibull extension;
down-then-up HA × λ, γ = 1⇒ Gompertz
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It can also be shown that the APGW distribution retains membership of the log-
location-scale-log-concave family of distributions of Jones and Noufaily (2015) and
therefore, inter alia, unimodality of densities. We also now note, for future reference,
the attractive form of the quantile function associated with HA, namely QA(u) =
{HA(− log(1− u); 1, 1/κ)}
1/γ ≡ QA1(u; κ)
1/γ.
The new adaptation can also be used to widen the family of PGW distributions
by taking −1 < κ < 0. For clarity, temporarily define ψ = κ + 1 so that 0 < ψ < 1.
The APGW c.h.f. can then be written as
HA(t; γ, ψ) =
ψ
1− ψ
(
1−
1
{1 + (tγ/ψ)}1−ψ
)
.
This corresponds to a cure model with cure probability pψ ≡ limt→∞ exp(−HA(t; γ, ψ))
= exp{−ψ/(1−ψ)}. Since the (improper) survival function is in this case of the form
p
1−SC(t)
ψ , this cure model has an interpretation as the distribution of the minimum of
a Poisson number of random variables (e.g. cancer cells, tumours), each following the
lifetime distribution with survival function SC (e.g. Tsodikov et al. (2003)); here, the
Poisson parameter is ψ/(1− ψ) and SC(t) = {1 + (t
γ/ψ)}ψ−1 is the survival function
of a scaled Burr Type XII distribution. The hazard functions hA(t; γ, ψ) follow the
shape of their ψ → 1 limit — the log-logistic — being decreasing for γ ≤ 1 and
up-then-down otherwise.
The PGW distribution, and in slightly more complicated form the APGW dis-
tribution, exhibit interesting frailty relationships between members of the families
with different values of κ. We defer consideration of these frailty links to Jones et al.
(2018) where we exploit them to obtain a useful bivariate shared frailty model with
PGW/APGW marginal distributions. In addition, PGW and APGW distributions
are written as linear transformation models in the Appendix.
2.2 Why This Particular Choice for H0?
The PGW/APGW distribution shares the set of hazard behaviours listed in Table 1
with two other established two-shape-parameter lifetime distributions centred on the
Weibull distribution, namely, the generalised gamma (GG) and exponentiated Weibull
(EW) distributions; see Jones and Noufaily (2015). See Figure 1 for many examples
of just how similar the hazard shapes of all three distributions are; in Figure 1, we
have chosen the scale parameter such that each distribution has median one, used the
PGW vertical scaling and otherwise specified shape parameters γ, κ > 0 only so that
all three hazard functions behave as tγ−1 as t→ 0 and as tκγ−1 as t→∞.
Further effort to choose shape parameters to match hazard functions or other as-
pects of the distributions even more closely is possible and has been pursued for the
EW and GG distributions by Cox and Matheson (2014) and extended to the PGW
6
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Figure 1: Hazard functions of PGW (solid), GG (dashed), and EW (dot-dashed)
distributions for the values of γ and κγ specified along the top and down the left-
hand side of the figure, respectively. In each case, the scale parameter is chosen
such that the median of the distributions is one. Figures on the main diagonal of
the matrix of figures, in each of which the PGW, GG and EW hazard functions
are identical, correspond to Weibull distributions, the figure in the centre to the
exponential distribution.
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distribution (what they call the generalised Weibull distribution) by Matheson et al.
(2017). Cox and Matheson (2014) state that the “agreement between the two dis-
tributions [GG and EW] in our various comparisons, both graphically and in terms
of the K–L [Kullback-Leibler] distance, is striking”; after a similar K–L matching
exercise, Matheson et al. (2017) state that “the survival and hazard functions of the
[PGW] distribution and its matched GG are visually indistinguishable.” It remains,
therefore, to choose between APGW, GG and EW distributions on other grounds.
The GG distribution includes the Weibull and gamma distributions as special cases
and the lognormal as a limiting one; the EW distribution includes the Weibull and
exponentiated exponential distributions. However: we have been unable to match the
number of APGW’s advantageous properties as in the previous subsections by simi-
larly adapting either the GG or EW distributions; we prefer the breadth of/difference
between the wide range of distributions encompassed by the APGW distribution; and
we appreciate the greater tractability of the APGW distribution both mathematically
and computationally (for instance, its hazard function has a simpler form compared
with the GG — which involves an incomplete gamma function — and the EW).
3 Regression
3.1 Modelling Choices
Within our proposed APGW modelling framework, there are four parameters, φ, λ, γ,
and κ, which could potentially depend on covariates. Note that most classical mod-
elling approaches are based on having a single covariate-dependent distributional pa-
rameter, which we refer to as single parameter regression (SPR), where, understand-
ably, there is a particular emphasis on scale-type parameters, e.g., the accelerated
failure time (AFT) model (φ regression) and the proportional hazards (PH) model
(λ regression). However, in line with the flexibility of the APGW distribution it-
self, we also consider taking a flexible multi-parameter regression (MPR) approach in
which more than one parameter may depend on covariates (cf. Burke and MacKenzie
(2017), and references therein, for details of multi-parameter regression). The most
general linear APGW-MPR is, therefore, given by
log(φ) = xT τ, log(λ) = xTβ, log(γ) = xTα, log(κ + 1) = xT ν,
where log-link functions are used to respect the positivity of the parameters φ, λ and
γ, with a slightly different link function for κ to accommodate the fact that, within our
APGW, it can take values in the range (−1,∞) (see Section 2.1), x = (1, x1, . . . , xp)
T
is a vector of covariates, and τ = (τ0, τ1, . . . , τp)
T , β = (β0, β1, . . . , βp)
T , α = (α0, α1,
. . . , αp)
T , and ν = (ν0, ν1, . . . , νp)
T are the corresponding vectors of regression coeffi-
cients. In practice, we may not necessarily have the same set of covariates appearing
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in all regression components, and, in our current notation, this can be handled by
setting various regression coefficients to zero.
As mentioned in Section 1, we could extend the above regression specification via
non-parametric regression functions of x, but this is beyond the scope of this pa-
per and, indeed, the MPR approach is, in itself, already flexible without this added
complexity. Furthermore, although the general APGW-MPR model offers the oppor-
tunity of four regression components simultaneously, this full flexibility is unlikely to
be required in practice. In particular, it is well known that φ and λ coincide in the
Weibull distribution so that only one scale parameter is needed in this case, i.e., φ
and λ are non-identifiable when κ = 1. Moreover, our numerical studies (Sections 4
and 5) suggest that, outside of the Weibull, this is effectively much more generally
true. Specifically, although φ and λ are theoretically identifiable in the non-Weibull
cases, the parameters are nonetheless nearly non-identifiable in finite samples, which
is an apparently new finding in the literature. Thus, in general, we should fix either
φ = 1 or λ = 1, but we would not simultaneously fix φ = λ = 1 as a scale parameter
is a core component for most statistical models.
A good practical choice is composed of the following pieces: (a) only one scale
parameter (φ or λ) depends on covariates, while the other is fixed at one as mentioned
above, (b) the γ shape parameter may depend on covariates, and (c) the κ shape
parameter is constant, i.e., only the intercept, ν0, is non-zero in the ν vector. This
choice provides a useful framework which incorporates, depending on the choice of
scale regression, either an AFT (τ) or PH (β) component, allows for non-AFT/non-
PH effects via the α coefficients associated with the power parameter (Section 3.2),
and automatically selects the underlying baseline distribution via ν0 from a range of
popular survival distributions (Table 2) including defective distributions, i.e., cure
models (Section 2.1).
3.2 Suggested models: M(τ, α) and M(β, α)
LetM(τ, α) andM(β, α) denote the two models suggested in the previous paragraph,
e.g., the latter is the model with β and α regression components, along with the shape
parameter ν0 (but where τ is a vector of zeros). More generally, beyond these two
models, we will use this notation throughout the paper where the arguments of M(·)
indicate which regression components are present in the model, the absence of either
β or τ indicating that this is a vector of zeros. Irrespective of the presence of α
or ν regression components in this M(·) notation, we assume that α0 and ν0 are
always present since these are needed to characterise the baseline distribution and
the shape of its hazard function (see Tables 1 and 2). Thus, for example, M(τ) and
M(β) are, respectively, AFT and PH models with two shape parameters (α0 and
ν0), M(β, α, ν) is a model which extends the suggested M(β, α) model so that the ν
9
regression component is also present, and M(β, τ, α, ν) is the most general APGW-
MPR model.
We first consider model M(τ, α) which extends the basic AFT model, M(τ), via
the incorporation of the α regression component. Now suppose that xj is a binary
covariate and let x(−j) = (1, x1, . . . , xj−1, 0, xj+1, . . . , xp)
T be the covariate vector with
xj set to zero so that we may write x
T τ = xjτj + x
T
(−j)τ and x
Tα = xjαj + x
T
(−j)α.
As this model extends the AFT model, it is natural to consider its quantile function
which is given by
Q(u|x) = exp(−xT τ)QA1(u; κ)
exp(−xTα)
where QA1(u) = HA(− log(1− u); 1, 1/κ) is the “baseline” quantile function defined
in Section 2.1. We can then inspect the quantile ratio
QRj(u) =
Q(u|xj = 1)
Q(u|xj = 0)
= exp(−τj)QA1(u; κ)
exp(−xT
(−j)
α){exp(−αj)−1}
where we see that αj is the key parameter in determining the u-dependence. In
particular, since QA1(u; κ) is an increasing function of u, QRj(u) increases when
αj < 0, decreases when αj > 0, and is constant (i.e., the usual AFT case) when
αj = 0. Hence, the αj coefficient characterises the nature of the effect of the binary
covariate xj , and provides a test of the AFT property for that covariate.
Now consider the model M(β, α) which extends the PH model, M(β) , and whose
hazard function is given by
h(t|x) = exp(xTβ) hA(t; exp(x
Tα), κ)
where hA(t; γ, κ) is defined in (3). The hazard ratio for the binary covariate xj is
HRj(t) =
h(t|xj = 1)
h(t|xj = 0)
= exp(βj + αj) t
exp(xT
(−j)
α){exp(αj )−1}g(t;αj, x
T
(−j)α, κ)
where
g(t;αj, x
T
(−j)α, κ) =
(
texp(αj+x
T
(−j)
α) + κ+ 1
t
exp(xT
(−j)
α)
+ κ+ 1
)κ−1
.
Clearly, αj characterises departures from proportional hazards asHRj(t) is a constant
when αj = 0. For κ ≥ 0, we have that limt→0HRj(t) = 0 and limt→∞HRj(t) = ∞
when αj > 0, while limt→0HRj(t) = ∞ and limt→∞HRj(t) = 0 when αj < 0.
Furthermore, it can be shown that HRj(t) varies monotonically in t in the following
cases: (i) κ ≥ 1, or (ii) 0 < κ < 1 and αj /∈ (log κ,− log κ). (We do not know about
monotonicity or otherwise in the remaining cases.)
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From the above we see that, within the suggested M(τ, α) and M(β, α) models,
the parameters play the following roles: the scale coefficients (τ or β) control the
overall size of the effect where negative coefficients correspond to longer lifetimes;
the α shape coefficients describe how covariate effects vary over the lifetime, i.e.,
permitting non-AFT and non-PH effects; and the ν0 shape parameter characterises
the baseline distribution. Note that we could, alternatively, achieve non-constant
covariate effects via the ν regression component rather than the α component, i.e.,
using M(β, ν) rather than M(β, α). However, in this case, the interpretation is that
such non-constant effects are due to populations which arise from structurally different
distributions, rather than different shapes within a given baseline distribution. The
latter is arguably more natural as it creates a separation of parameters whereas, in the
former, distribution selection and non-constant covariate effects are intertwined. Of
course, this is not to say that models with ν components instead of, or in combination
with, α components will never be useful in practice. However, we are highlighting
practical merits of the M(τ, α) and M(β, α) models and, indeed, the general use of
these models is motivated by the numerical studies of Sections 4 and 5.
3.3 Estimation
Consider the model formulation given in (1) with all four regression components, i.e.,
the M(τ, β, α, ν) model. (While we advocate the special cases M(τ, α) or M(β, α),
we write the estimation equations in a general form below so as to unify all potential
model structures. In particular, estimation of both τ and β is not recommended in
practice.) Let φi = exp(x
T
i τ), λi = exp(x
T
i β), γi = exp(x
T
i α) and κi = exp(x
T
i ν) −
1 be the covariate-dependent distributional parameters for the ith individual with
covariate vector xi = (1, xi1, . . . , xip)
T , and τ , β, α, and ν are the associated vectors
of regression coefficients. Allow independent censoring by attaching to each individual
an indicator δi which equals one if the response is observed, and zero if it is right-
censored. The log-likelihood function is then given by
ℓ(θ) =
n∑
i=1
[
δi
{
log
(
λiγizi
ti
)
+m0(zi; κi)
}
− λiH0(zi; κi)
]
where θ = (τT , βT , αT , νT )T , zi = (φiti)
γi and, in our proposed APGW case,
H0(t; κ) = HA(t; 1, κ) =
κ+ 1
κ
{(
1 +
t
κ + 1
)κ
− 1
}
,
m0(t; κ) = log h0(t; κ) = (κ− 1) log
(
1 +
t
κ+ 1
)
.
As usual, the log-likelihood function can be maximised by solving the score equations
(UTτ X, U
T
β X, U
T
αX, U
T
ν X)
T = 04p×1
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where X is an n× p matrix whose ith row is xi, 04p×1 is a 4p× 1 vector of zeros and
Uτ , Uβ , Uα, and Uν are n× 1 vectors whose ith elements are as follows:
Uτ,i = δi {γi + γizim
′
0(zi; κi)} − λiγizi h0(zi; κi),
Uβ,i = δi − λiH0(zi; κi),
Uα,i = δi [1 + log(zi) {1 + zim
′
0(zi; κi)}]− λizi log(zi)h0(zi; κi),
Uν,i =
[
δi
{
κi + 1
κi − 1
m0(zi; κi)− zim
′
0(zi; κi)
}
−λi
κi + 1
κ2i (κi − 1)
{
κi − 1 +
(
1 +
t
κi + 1
)κi
a0(zi; κi)
}]
,
where a0(t; κ) = κ(κ+ 1)m0(t; κ)− κ
2tm′0(t; κ)− κ + 1.
Note that the vectors Uτ,i, Uβ,i and Uα,i are written generically so that they apply
to any model of the form given in (1), i.e., they are not specific to the APGW case;
the form of Uν,i, on the other hand, uses the way in which H0 and hence m0 and m
′
0
depend on κ. Thus, although the APGW is certainly a flexible choice (see Section 2),
the first three score components extend immediately to other baseline distributions
by replacing H0 (and, consequently, m0 and m
′
0). Estimation then proceeds once the
functional form of Uν,i has been re-evaluated.
Furthermore, one may, alternatively, prefer to maintain an unspecified baseline dis-
tribution, whereby ν represents an infinite-dimensional (possibly covariate-
independent) parameter vector. In this case, estimation equations for the regres-
sion coefficients τ , β, and α can be based on (UTτ X, U
T
β X, U
T
αX) where H0 is re-
placed with an appropriate non-parametric estimator (and, similarly, for m0 and m
′
0).
However, while non-parametric estimation of H0 is reasonably straightforward (say,
using a Nelson-Aalen-type estimator), it is well known that terms such as m0 and
m′0, which involve h0 and h
′
0, are more difficult to estimate consistently. We note
that semi-parametric versions of the M(τ, β) and M(τ, α) models have respectively
been developed by Chen and Jewell (2001) and Burke et al. (2018). However, we are
unaware of a semi-parametric M(τ, β, α) model in the literature. In any case, such
semi-parametric models are beyond the scope of the current paper and, indeed, a
flexible parametric framework can cover a wide variety of applications as previously
discussed in Section 1.
4 Simulation Studies
4.1 Without Covariates
Before considering estimation in the presence of covariates, we first investigate esti-
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mation in the context of the APGW model with no covariates. Thus, we simulated
data from the APGW distribution parameterised in terms of the following uncon-
strained parameters: τ = logφ, β = log λ, γ = logα and ν = log(κ + 1). The values
of the first three parameters were fixed at τ = 0.8, β = 0.5, α = −0.3, respectively,
while ν was varied such that ν ∈ {0.00, 0.22, 0.41, 0.69, 1.10, 1.61,∞} (rounded to two
decimal places); note that ν = 0, ν = 0.69 and ν = ∞ correspond, respectively, to
the log-logistic (κ = 0), Weibull (κ = 1) and Gompertz (κ = ∞) distributions. Fur-
thermore, the sample size was fixed at 1000 and censoring times were generated from
an exponential distribution such that, for each ν value, the censoring rate was fixed
at approximately 30%. Within each of the seven simulation scenarios (i.e., varying
ν), we fitted three different models with the aim of understanding the identifiability
of parameters in a finite, but reasonably large, sample: (i) estimate all parameters,
(ii) fix β at its true value, and (iii) fix β at zero. Thus, τ , α and ν are estimated in all
three models. We also considered additional scenarios where α = 0.3 but the results
are similar and, therefore, are not shown here.
Each scenario was replicated 1000 times, and the results are contained in Table 3.
Clearly, estimation is unstable in model (i), i.e., standard errors are large. This
instability arises as a consequence of attempting to estimate the scale parameters,
τ and β, simultaneously. Indeed, in all cases where these parameters are estimated
simultaneously, we have found that corr(τˆ , βˆ) ≈ 1. Of course, it is well known that
τˆ and βˆ are perfectly co-linear in the Weibull case (ν = 0.69), but it is interesting
to find that this extends (approximately) beyond the Weibull distribution. This
appears to be a new finding in survival modelling and implies that these parameters
play somewhat similar roles across a range of popular lifetime distributions (it also
explains the large standard errors observed in Table 2 of Chen and Jewell (2001)).
This instability vanishes once β is fixed. In particular, when β is set to its true value
of β = 0.5 (i.e., model (ii)), the estimates display very little bias. Moreover, when β
is set to an incorrect value, β = 0.0 (i.e., model (iii)), τˆ converges consistently to a
value in the range 1.4–1.5 which compensates for the incorrect specification of β and
varies smoothly with ν; the value of νˆ changes somewhat from its value in model (ii),
but, interestingly, αˆ does not. Furthermore, the fitted survivor curves for both models
(not shown) are close to the truth, i.e., there is no reduction in quality of model fit as
a consequence of fixing β to zero. Similarly (but not shown here), estimation is also
stable if τ is fixed and β is estimated, and the fitted survivor curves are again close
to the truth. Therefore, the choice of scale — either τ or β (fixing the other to zero)
— behaves, approximately, as a model reparameterisation (which it is, exactly, in the
Weibull case). We note that, for both models (ii) and (iii), the standard error of νˆ
can be large when ν is large. However, this is not a concern as it is a consequence
of the fact that the APGW distribution changes very little over a range of large ν
values.
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Table 3: Median and standard error (in brackets) of estimates
Model ν τˆ βˆ αˆ νˆ
(i)
β : est
0.00 1.87 (6.93) -0.21 (4.98) -0.26 (0.12) 0.18 (4.38)
ν : est
0.22 2.24 (11.52) -0.54 (8.38) -0.26 (0.15) 0.39 (7.24)
0.41 2.83 (11.55) -0.98 (8.58) -0.26 (0.20) 0.49 (7.55)
0.69 2.11 (8.52) -0.48 (6.54) -0.31 (0.22) 0.76 (7.93)
1.10 0.83 (4.30) 0.38 (3.32) -0.33 (0.14) 1.18 (6.82)
1.61 0.53 (2.76) 0.57 (2.13) -0.32 (0.11) 12.32 (6.47)
∞ 1.10 (1.53) 0.19 (1.21) -0.32 (0.09) 13.04 (6.40)
(ii)
β : true
0.00 0.81 (0.15) 0.50 — -0.30 (0.05) 0.00 (0.11)
ν : est
0.22 0.79 (0.15) 0.50 — -0.30 (0.05) 0.23 (0.15)
0.41 0.80 (0.15) 0.50 — -0.30 (0.05) 0.40 (0.19)
0.69 0.79 (0.15) 0.50 — -0.30 (0.06) 0.71 (0.31)
1.10 0.79 (0.16) 0.50 — -0.30 (0.06) 1.12 (1.59)
1.61 0.80 (0.14) 0.50 — -0.30 (0.05) 1.65 (3.72)
∞ 0.84 (0.09) 0.50 — -0.28 (0.04) 13.05 (6.23)
(iii)
β : zero
0.00 1.52 (0.12) 0.00 — -0.29 (0.05) 0.15 (0.09)
ν : est
0.22 1.50 (0.13) 0.00 — -0.29 (0.06) 0.33 (0.12)
0.41 1.49 (0.13) 0.00 — -0.30 (0.05) 0.48 (0.14)
0.69 1.48 (0.13) 0.00 — -0.30 (0.06) 0.68 (0.19)
1.10 1.44 (0.13) 0.00 — -0.31 (0.06) 0.99 (0.27)
1.61 1.44 (0.14) 0.00 — -0.31 (0.06) 1.27 (1.46)
∞ 1.42 (0.13) 0.00 — -0.31 (0.06) 2.04 (4.50)
All numbers are rounded to two decimal places. For the models with fixed parameters, the
“estimated” value shown is the value at which the parameter is fixed, and its standard error
is then indicated by “—”. While τ and β are not simultaneously estimable when ν = 0.69
(Weibull case), the estimation procedure still yields values (which depend completely on initial
values) such that the constant λφγ is preserved in the sense that its value is the same as the
case where one of β or τ were held constant.
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4.2 With a Covariate
We simulated survival times according to the APGW distribution with parameters
φ = exp(τ0 + τ1X), λ = exp(β), γ = exp(α0 + α1X), and κ = exp(ν)− 1 where X ∼
Bernoulli(0.5), ν was varied according to the set {0.00, 0.22, 0.41, 0.69, 1.10, 1.61,∞},
and the remaining parameter values were fixed at τ0 = 0.8, τ1 = 0.6, β = 0.0,
α0 = 0.2, and α1 = −0.5; these values were selected to yield realistic survival times.
In the notation of Section 3.2, the true model is M(τ, α). As in Section 4.1, the
sample size and censored proportion were, respectively, set at 1000 and 30% (with
censoring times generated from an exponential distribution). Within each of the seven
scenarios (i.e., varying ν), we fitted the following three regression models: the more
general M(τ, β, α), the true M(τ, α), and the misspecified M(β, α), respectively. The
results, based on 1000 simulation replicates, are given in Table 4.
Mirroring the case with no covariates (Section 4.1), we find that estimation is un-
stable when attempting to estimate τ and β coefficients simultaneously inM(τ, β, α),
whereas estimation is stable in both the true M(τ, α) and the misspecified M(β, α)
models. In the latter, β coefficients converge consistently to values varying smoothly
with ν. Note that the results are broadly similar for smaller sample sizes of n = 500
and n = 100 (see Appendix for details).
We now consider model fit by inspecting the estimated baseline survivor curves,
i.e., the survivor curve for an individual with X = 0 which we denote by S0(t). In
particular, we focus on this estimated baseline survivor function evaluated at three
true quantiles, namely, Q0(u), u = 0.1, 0.5, 0.9, since Sˆ0(Q0(u)) is an estimate of the
probability 1− u. Boxplots of these estimates over simulation replicates arising from
the true model, M(τ, α), and the misspecified model, M(β, α), are shown in Figure
2. We also display the estimates from two simpler (misspecified) models, M(τ) and
M(β), wherein X has been dropped from the α component (specifically, α1 is set to
zero in these simpler models). Clearly both M(τ, α) and M(β, α) fit the data very
well (apart from a little bias inM(β, α) when ν =∞), i.e., the choice of using a τ or β
regression component does not alter the model fit much (again mirroring the findings
of Section 4.1). On the other hand, when the α regression is dropped, the quality of
the model fit decreases considerably as this represents a model misspecification in a
much stronger sense than switching from M(τ, α) to M(β, α).
5 Data Analysis
5.1 Lung Cancer
We now consider our modelling framework in the context of a lung cancer study which
was the subject of a 1995 Queen’s University Belfast PhD thesis by P. Wilkinson (see
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Table 4: Median and standard error (in brackets) of estimates
Model(τ, β, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.98 (1.21) 0.55 (1.28) -0.20 (1.37) 0.02 (0.70) 0.23 (0.13) -0.50 (0.18) 0.05 (0.76)
0.22 0.98 (1.40) 0.51 (2.08) -0.20 (1.63) 0.04 (1.61) 0.23 (0.17) -0.50 (0.24) 0.27 (0.44)
0.41 1.00 (1.65) 0.57 (2.95) -0.24 (1.99) 0.10 (2.48) 0.24 (0.18) -0.51 (0.26) 0.40 (0.39)
0.69 1.18 (2.13) 0.34 (4.39) -0.43 (2.63) 0.19 (3.85) 0.22 (0.20) -0.51 (0.22) 0.61 (3.56)
1.10 0.39 (1.50) 0.08 (2.88) 0.35 (1.89) 0.21 (2.66) 0.17 (0.12) -0.49 (0.18) 1.31 (6.88)
1.61 0.55 (1.00) 0.47 (1.62) 0.26 (1.34) -0.04 (1.61) 0.19 (0.12) -0.51 (0.18) 2.60 (7.04)
∞ 0.88 (0.53) 0.69 (0.88) -0.14 (0.81) -0.06 (0.99) 0.21 (0.12) -0.51 (0.17) 15.12 (6.46)
Model(τ, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.80 (0.09) 0.60 (0.13) 0.00 — 0.00 — 0.21 (0.06) -0.50 (0.06) 0.00 (0.06)
0.22 0.81 (0.09) 0.60 (0.12) 0.00 — 0.00 — 0.21 (0.06) -0.50 (0.06) 0.22 (0.09)
0.41 0.80 (0.08) 0.59 (0.10) 0.00 — 0.00 — 0.20 (0.06) -0.50 (0.06) 0.40 (0.11)
0.69 0.79 (0.08) 0.60 (0.10) 0.00 — 0.00 — 0.20 (0.06) -0.50 (0.06) 0.70 (0.17)
1.10 0.80 (0.09) 0.60 (0.09) 0.00 — 0.00 — 0.20 (0.06) -0.50 (0.06) 1.12 (0.84)
1.61 0.81 (0.08) 0.60 (0.08) 0.00 — 0.00 — 0.20 (0.07) -0.50 (0.06) 1.59 (2.44)
∞ 0.82 (0.05) 0.62 (0.06) 0.00 — 0.00 — 0.22 (0.05) -0.50 (0.06) 13.16 (6.78)
Model(β, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.00 — 0.00 — 0.88 (0.11) 0.03 (0.08) 0.18 (0.05) -0.52 (0.05) -0.36 (0.12)
0.22 0.00 — 0.00 — 0.91 (0.11) 0.04 (0.08) 0.18 (0.06) -0.51 (0.06) -0.06 (0.15)
0.41 0.00 — 0.00 — 0.93 (0.13) 0.05 (0.09) 0.19 (0.06) -0.50 (0.06) 0.21 (0.21)
0.69 0.00 — 0.00 — 0.98 (0.13) 0.06 (0.09) 0.20 (0.06) -0.50 (0.06) 0.72 (0.35)
1.10 0.00 — 0.00 — 1.03 (0.14) 0.07 (0.11) 0.22 (0.06) -0.50 (0.07) 1.83 (4.33)
1.61 0.00 — 0.00 — 1.18 (0.10) 0.08 (0.12) 0.27 (0.05) -0.50 (0.07) 15.16 (6.52)
∞ 0.00 — 0.00 — 1.54 (0.10) 0.10 (0.14) 0.37 (0.05) -0.48 (0.07) 16.88 (1.28)
All numbers are rounded to two decimal places. For the models with fixed parameters, the
“estimated” value shown is the value at which the parameter is fixed, and its standard error is
then indicated by “—”.
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Figure 2: Boxplots of estimated baseline survivor probabilities evaluated at the true
90th, 50th, and 10th percentile times, respectively (such that the true probabilities
are 0.1, 0.5, and 0.9), vertically stacked for each of four fitted models indicated by
the x-axis labels.
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Burke and MacKenzie (2017)). This study concerns 855 individuals who were diag-
nosed with lung cancer between 1st October 1991 and 30th September 30 1992, who
were then followed up until 30th May 1993 (approximately 20% of survival times were
right-censored). The main aim of this study was to investigate differences between
the following treatment groups: palliative care, surgery, chemotherapy, radiotherapy,
and a combined treatment of chemotherapy and radiotherapy. In our analysis we
take palliative care (which is a non-curative treatment providing pain relief) as the
reference category. Note that, while various other covariates were captured for each
individual, our main aim here is to explore the flexibility of our general modelling
scheme in the context of the treatment variable.
As discussed in Section 3, we advocate the use of M(β, α) and M(τ, α) since they
offer a flexible extension of the popular PH and AFT models (i.e., M(β) and M(τ),
respectively) in which the α coefficients indicate non-PH/non-AFT effects (see Section
3.2), and where the baseline distribution is selected via the parameter ν0 = log(κ+1).
Thus, we fitted these two models, and their simpler PH and AFT counterparts, to
the lung cancer data. We also fitted M(β, ν) and M(τ, ν) for comparison, albeit we
have argued in Section 3.2 that these are perhaps somewhat less natural. These six
fitted models are summarised in Table 5.
We immediately see that the largest AIC/BIC values are associated with the
simpler single component (i.e., τ and β only) models which suggests that these models
are not sufficiently flexible to capture the more complex non-PH/non-AFT effects
observed here. Although, in this particular application, the AFT (τ only) model has
lower AIC/BIC values than that of the PH (β only) model, the fit can be greatly
improved by modelling shape (either α or ν) in addition to scale. Although the best-
fitting model here is M(β, ν), the difference is negligible compared with the models
we favour, M(β, α) and M(τ, α). Interestingly, these latter two models have very
close AIC/BIC values, indicating that the choice of τ or β component is not at all
important here (in line with the findings of Section 4.2). The use of more than two
regression components did not yield further improvements in fit (models not shown),
and, moreover, estimation of such models tends to be unstable — particularly, of
course, those with two scale regression components (see also Section 4). Note that
we have also avoided shape-only regression models, i.e., M(α), M(ν), and M(α, ν),
as, typically, models without scale components are not of interest, and, as we would
expect, these models fit the current data very poorly indeed (with ∆AIC > 600).
We now consider the PH-APGW model, M(β), and the two associated shape-
regression extensions, M(β, α) and M(β, ν), in more detail. The advantage, in terms
of model fit, of shape regression components is clear from Figure 3, while theM(β, α)
and M(β, ν) models themselves are virtually indistinguishable. Table 6 displays the
estimated regression coefficients. We can see that both M(β) and M(β, α) suggest a
baseline distribution which is between a log-logistic (ν = 0) and a Weibull (ν = 0.69),
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Table 5: Summary of models fitted to lung cancer data
Model M(β) M(τ) M(β, α) M(τ, α) M(β, ν) M(τ, ν)
dim(θ) 7 7 11 11 11 11
ℓ(θˆ) -1956.5 -1943.5 -1927.0 -1926.6 -1925.9 -1930.3
∆AIC 53.1 27.2 2.2 1.5 0.0 8.9
∆BIC 34.1 8.2 2.2 1.5 0.0 8.9
ℓ(θˆ), the value of the log-likelihood; dim(θ), the dimension of the model, i.e.,
number of parameters; ∆AIC, the AIC values for each model minus AICM(β,ν) =
3873.8 (the lowest AIC in the set); ∆BIC, analogous to ∆AIC where the lowest
BIC is BICM(β,ν) = 3926.1.
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Figure 3: Kaplan-Meier survivor curves (step, solid) for lung cancer treatment groups
(P = palliative, C = chemotherapy, R = radiotherapy, CR = chemotherapy and
radiotherapy, and S = surgery) with fitted curves overlayed forM(β) (solid), M(β, α)
(dashed), and M(β, ν) (dotted).
while M(β, ν) assumes a separate baseline distribution for each treatment group. In-
terestingly, in all three models, all shape parameters (ν and α) are positive which
indicates that the hazards are increasing with time in each treatment group (Table
1). While all three models are in agreement when it comes to the overall effectiveness
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of each treatment as viewed in terms of the scale coefficients (albeit the chemother-
apy effect is only statistically significant in M(β)), the positive shape coefficients
in M(β, α) suggest that the effectiveness of each treatment reduces to some extent
over time (see Section 3.2) – especially in the case of the combined treatment of
chemotherapy and radiotherapy.
Table 6: Selected lung cancer models
Model(β) Model(β, α) Model(β, ν)
Scale Scale Shape Scale Shape
Intercept -1.40 (0.08) -1.13 (0.09) 0.12 (0.07) -1.04 (0.10) 0.21 (0.06)
Palliative 0.00 — 0.00 — 0.00 — 0.00 — 0.00 —
Surgery -2.18 (0.23) -4.77 (0.97) 1.06 (0.28) -3.96 (0.66) 0.55 (0.15)
Chemo -0.38 (0.17) -0.55 (0.33) 0.13 (0.18) -0.60 (0.36) 0.11 (0.13)
Radio -0.56 (0.09) -1.46 (0.21) 0.52 (0.11) -1.48 (0.19) 0.36 (0.06)
C+R -0.86 (0.20) -5.13 (0.96) 1.50 (0.22) -3.57 (0.60) 0.82 (0.13)
αˆ0 0.15 (0.08) ∗ 0.27 (0.07)
νˆ0 0.46 (0.06) 0.35 (0.05) ∗
The ∗ symbol indicates that the shape parameter already appears as the intercept in the shape
regression component.
The hazard ratios for the models in Table 6 are shown in Figure 4 where those
of M(β, α) and M(β, ν) are quite similar. They suggest that while the various treat-
ments reduce the hazard in the first few months, their effect is weakened over time
and, perhaps, even become inferior to palliative care in the longer term (however,
note that very few individuals remain in the sample beyond 15 months). Clearly
SPR models, such as M(β), cannot account for covariate effects of this sort.
It is worth highlighting the fact that the basic findings here are qualitatively
similar to those of Burke and MacKenzie (2017) who analysed this lung cancer dataset
using Mκ=1(β, α), i.e., a Weibull MPR model. However, the framework of the current
paper permits us to consider a much wider range of model structures and distributions
in which Mκ=1(β, α) appears as a special case. In particular, M(β, α) from Table 6
yields a 95% confidence interval for κ, [0.28, 0.57], which does not support the Weibull
(κ = 1) baseline distribution. Furthermore, AICMκ=1(β,α) −AICM(β,α) = 57.6, and we
can confirm that the improvement in quality of fit is most evident in the palliative care
group (which Mκ=1(β, α) does not capture so well). Thus, although the basic findings
are unaltered in this particular application, the APGWMPR approach yields a better
solution in which uncertainty in selecting the baseline distribution is accounted for.
Of course, the APGW MPR model will readily adapt to other applications which
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Figure 4: Hazard ratios for each lung cancer treatment relative to palliative care for
M(β) (solid), M(β, α) (dashed), and M(β, ν) (dotted). Line of equality (grey) also
shown.
might differ significantly (both qualitatively and quantitatively) from Mκ=1(β, α).
5.2 Melanoma
The Eastern Cooperative Oncology Group (ECOG) trial “EST 1684” was a random-
ized controlled trial to investigate the adjuvant (i.e., post-surgery) chemotherapy drug
“IFNα-2b” in treating melanoma (Kirkwood et al., 1996). The outcome variable was
relapse-free survival, i.e., time from randomization until the earlier of cancer relapse
or death. Patients were recruited to the study between 1984 and 1990, and the study
ended in 1993. In total, 284 patients were recruited of which 140 were assigned to the
control group, and 144 were assigned to the treatment group. This dataset is available
in the R package smcure (Chao et al., 2012), and variations of it have appeared in
the cure model literature (Chen et al., 1999; Ibrahim et al., 2001).
As in Section 5.1, we fitted the following models: M(β), M(τ), M(β, α), M(τ, α),
M(β, ν), and M(τ, ν); the results are summarised in Table 7. In this case, the two-
component models do not provide a large improvement over the one-component mod-
els, and M(τ) has the lowest AIC and the second-lowest BIC (M(τ, ν) has the lowest
BIC); the AIC and BIC values for M(β) are not much larger than for M(τ). The
models M(β), M(τ), and M(τ, ν) are compared to the Kaplan-Meier (KM) curves in
Figure 5. The fitted M(β) and M(τ, ν) curves are similar, and are close to the KM
curves. The fitted M(τ) curves converge later in time, which, visually, look worse
compared to the KM curves. However, note that there is very little data in the right
tail so that converging curves are plausible when viewed with the level of uncertainty
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in the tail.
Table 7: Summary of models fitted to melanoma data
Model M(β) M(τ) M(β, α) M(τ, α) M(β, ν) M(τ, ν)
dim(θ) 4 4 5 5 5 5
ℓ(θˆ) -368.8 -368.0 -367.7 -367.9 -368.2 -366.6
∆AIC 2.4 0.8 2.1 2.6 3.2 0.0
∆BIC 1.6 0.0 5.0 5.5 6.1 2.9
ℓ(θˆ), the value of the log-likelihood; dim(θ), the dimension of the model, i.e.,
number of parameters; ∆AIC, the AIC values for each model minus AICM(τ,ν) =
743.2 (the lowest AIC in the set); ∆BIC, analogous to ∆AIC where the lowest
BIC is BICM(τ) = 758.6.
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Figure 5: Kaplan-Meier survivor curves (step, solid) for melanoma control and treat-
ment groups with fitted curves overlayed for M(β) (solid), M(τ) (dashed), and
M(τ, ν) (dotted).
The parameter estimates for M(β), M(τ), and M(τ, ν) are shown in Table 8.
Firstly note that the scale coefficient of treatment is negative which indicates that
treatment improves survival. Furthermore, for M(β) and M(τ), note that the pa-
rameter κ = exp(ν0) − 1 is negative, and, similarly, for M(τ, ν), the estimated κ
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is negative in each treatment group. Thus, all three models point towards a cure
proportion. The fact that the power shape parameter, γ = exp(α), is greater than
one for all three models means that the hazard function has an up-then-down shape.
This type of hazard function is commonly observed in the cure literature since the
population becomes increasingly composed of cured individuals (i.e., zero hazard)
over time.
Table 8: Selected melanoma models
Model(β) Model(τ) Model(τ, ν)
Scale Scale Scale Shape
Intercept 0.60 (0.16) 0.65 (0.14) 0.67 (0.15) -0.45 (0.05)
Control 0.00 — 0.00 — 0.00 — 0.00 —
Treatment -0.36 (0.14) -0.52 (0.20) -0.53 (0.19) -0.14 (0.08)
αˆ0 0.36 (0.07) 0.44 (0.08) 0.45 (0.08)
νˆ0 -0.73 (0.11) -0.51 (0.05) ∗
The ∗ symbol indicates that the shape parameter already appears as the intercept
in the shape regression component.
Table 9: Estimated melanoma cure proportions with 95% confidence intervals
Model Treatment Control Difference
M(β) 0.30 (0.21,0.39) 0.18 (0.10,0.26) 0.12 (0.03,0.21)
M(τ) 0.22 (0.15,0.30) = Treatment —
M(τ, ν) 0.24 (0.18,0.39) 0.11 (0.09,0.27) 0.12 (-0.02,0.23)
pDifference = pTreatment − pcontrol.
When −1 < κ < 0, the APGW-MPR cure proportion is given by
exp{λ(κ + 1)/κ} > 0, i.e., the cure proportion depends on κ and λ. Therefore,
M(β) and M(τ, ν) suggest that the cure proportion depends on treatment, while
M(τ) suggests that it does not. The estimated cure proportions, along with 95%
confidence intervals, are shown in Table 9. Had we fixed to a log-logistic baseline
(i.e., κ = 0), the resulting Mκ=0(β) and Mκ=0(τ) models (not shown) provide an
extremely poor fit to the data. This is noteworthy as even the heaviest-tail non-cure
APGW model is not supported by the data (and, of course, a Weibull baseline is
worse still). The heaviness of tail here can only be supported within the APGW
family by a cure model.
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6 Discussion
Our proposed APGW-MPR modelling framework is highly flexible and can adapt
readily to a wide variety of applications in survival analysis and reliability. In par-
ticular, this framework includes the practically important AFT and PH models, and
generalises them through shape regression components. Furthermore, the APGW
baseline model covers the primary shapes of hazard function (constant, increasing,
decreasing, up-then-down, down-then-up) within some of the most popular survival
distributions (log-logistic, Burr type XII, Weibull, Gompertz) using only two shape
parameters.
In practice, the full four-component APGW-MPR model is likely to be more flex-
ible than is required for most purposes. In fact, we suggest that covariates should
appear via just one scale-type component (τ or β), along with the α shape compo-
nent which permits survivor functions with differing shapes and indicates departures
from more basic AFT or PH effects, while ν = log(κ + 1) is a covariate-independent
parameter which allows us to choose among distributions within one unified frame-
work. We have found that the scale-type parameters (τ and β) are highly intertwined
in the sense that they cannot be estimated simultaneously within the same model
reliably, and are highly correlated. This is true across the full range of distributions
(varying ν), going well beyond the well-known Weibull case in which the two scale
components are equivalent. The implication of this is that, in terms of performance
gain, the movement from AFT to PH modelling (or vice versa) might not be very
large, whereas we have found that modelling the shape is a more fruitful alteration
to the regression specification.
Finally, the perspective of this paper has been to investigate survival modelling
generally, to cover some of the most popular models, and to discover some of the
better modelling choices that can be made within this framework. Although we have
developed these ideas in a fully parametric context, non-parametric equivalents, while
possible, are beyond the scope of the present paper (but are investigated in a separate
line of work (Burke et al., 2018)). However, it is worth highlighting that perhaps too
much emphasis is placed on non-/semi-parametric approaches in survival analysis
whereby undue weight is attached to the flexibility of the baseline distribution in
comparison to the flexibility of its regression structure. Our general approach to
survival modelling provides a framework within which one can consider the most
important components of survival modelling (including which might potentially be
modelled non-parametrically), and we believe that this insight can lead to better
modelling practice in general.
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Appendix
A The (A)PGW Distribution as a Transformation
Model
Linear transformation models (c.f. Kalbfleisch and Prentice (2002, sec. 7.5); Zeng and Lin
(2007)) are concerned with c.h.f.’s of the form
HT (t) = w(θH0(t)) (A:1)
where θ > 0 depends log-linearly on covariates and both the transformation function
w and baseline function H0 are c.h.f.’s. It is easy to see that the (A)PGW c.h.f.’s HN
and HA are of the form (A:1). Either is a transformation model with H0 the Weibull
c.h.f. tγ ; in terms of the overall model, whenever the Weibull is used as baseline,
θ−1/γ is the horizontal scale parameter so that when covariates are included only in
it, the transformation model is an accelerated failure time model. The transformation
w is a version of the Box-Cox transformation given, in the simpler case of HN , by
w(y) = (1 + y)κ − 1 (Box and Cox, 1964; Yeo and Johnson, 2000).
If Y is the lifetime random variable following the transformation model with,
for simplicity, c.h.f. HN , then the model can also be written in the form γ log Y =
− log θ + logE where E follows the distribution with c.h.f. (1 + y)κ − 1.
B Simulation Studies with Smaller Samples
This section displays analogous results to those of Table 4 from the main paper but
for n = 500 and n = 100 respectively.
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Table 10: Median and standard error (in brackets) of estimates when n = 500
Model(τ, β, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 1.06 (1.57) 0.57 (1.63) -0.25 (1.73) 0.01 (1.13) 0.23 (0.21) -0.49 (0.32) 0.07 (1.02)
0.22 1.30 (1.62) 0.45 (2.66) -0.52 (1.95) 0.21 (2.13) 0.27 (0.24) -0.53 (0.37) 0.27 (0.73)
0.41 1.05 (1.73) 0.81 (3.17) -0.19 (2.11) -0.03 (2.72) 0.27 (0.24) -0.50 (0.34) 0.35 (0.78)
0.69 0.88 (2.12) 0.45 (4.19) -0.15 (2.60) 0.19 (3.70) 0.21 (0.26) -0.51 (0.28) 0.65 (4.26)
1.10 0.43 (1.51) 0.26 (2.93) 0.33 (1.91) 0.04 (2.72) 0.15 (0.16) -0.49 (0.23) 1.53 (7.11)
1.61 0.53 (1.09) 0.40 (1.98) 0.25 (1.47) -0.01 (2.03) 0.19 (0.16) -0.50 (0.24) 14.75 (7.06)
∞ 0.91 (0.72) 0.68 (1.26) -0.15 (1.07) -0.02 (1.41) 0.19 (0.16) -0.51 (0.24) 15.43 (6.48)
Model(τ, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.79 (0.13) 0.60 (0.19) 0.00 — 0.00 — 0.20 (0.09) -0.50 (0.09) 0.00 (0.09)
0.22 0.80 (0.12) 0.59 (0.16) 0.00 — 0.00 — 0.20 (0.09) -0.50 (0.09) 0.22 (0.13)
0.41 0.79 (0.12) 0.58 (0.15) 0.00 — 0.00 — 0.20 (0.09) -0.50 (0.08) 0.42 (0.18)
0.69 0.80 (0.13) 0.58 (0.14) 0.00 — 0.00 — 0.20 (0.09) -0.50 (0.08) 0.72 (0.30)
1.10 0.79 (0.13) 0.60 (0.12) 0.00 — 0.00 — 0.20 (0.09) -0.51 (0.09) 1.13 (1.73)
1.61 0.80 (0.11) 0.60 (0.11) 0.00 — 0.00 — 0.20 (0.09) -0.50 (0.09) 1.62 (4.26)
∞ 0.84 (0.07) 0.62 (0.08) 0.00 — 0.00 — 0.24 (0.08) -0.51 (0.09) 13.84 (6.97)
Model(β, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.00 — 0.00 — 0.88 (0.16) 0.03 (0.12) 0.17 (0.08) -0.51 (0.08) -0.35 (0.18)
0.22 0.00 — 0.00 — 0.91 (0.17) 0.04 (0.11) 0.19 (0.08) -0.51 (0.08) -0.07 (0.23)
0.41 0.00 — 0.00 — 0.94 (0.18) 0.04 (0.12) 0.19 (0.08) -0.51 (0.08) 0.22 (0.30)
0.69 0.00 — 0.00 — 0.98 (0.20) 0.07 (0.14) 0.20 (0.09) -0.50 (0.09) 0.72 (0.94)
1.10 0.00 — 0.00 — 1.04 (0.17) 0.08 (0.15) 0.22 (0.08) -0.50 (0.09) 1.74 (5.10)
1.61 0.00 — 0.00 — 1.20 (0.15) 0.09 (0.17) 0.27 (0.07) -0.49 (0.10) 14.00 (7.03)
∞ 0.00 — 0.00 — 1.54 (0.15) 0.12 (0.20) 0.37 (0.08) -0.49 (0.10) 16.85 (1.76)
All numbers are rounded to two decimal places. For the models with fixed parameters, the
“estimated” value shown is the value at which the parameter is fixed, and its standard error is
then indicated by “—”.
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Table 11: Median and standard error (in brackets) of estimates when n = 100
Model(τ, β, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 1.32 (2.72) 0.88 (2.91) -0.49 (3.18) -0.01 (1.97) 0.39 (0.43) -0.52 (0.63) 0.08 (2.53)
0.22 1.29 (2.21) 0.85 (3.20) -0.39 (2.74) 0.01 (2.39) 0.38 (0.42) -0.49 (0.56) 0.17 (3.18)
0.41 1.10 (1.85) 0.83 (3.21) -0.22 (2.24) 0.02 (2.73) 0.35 (0.44) -0.51 (0.52) 0.24 (3.41)
0.69 0.87 (1.94) 0.67 (3.47) -0.14 (2.48) -0.03 (3.12) 0.21 (0.45) -0.49 (0.46) 0.87 (6.34)
1.10 0.61 (1.52) 0.50 (2.84) 0.05 (1.96) -0.02 (2.69) 0.17 (0.33) -0.52 (0.37) 12.66 (7.62)
1.61 0.70 (1.22) 0.57 (2.46) 0.05 (1.72) 0.05 (2.52) 0.17 (0.28) -0.52 (0.37) 15.31 (7.02)
∞ 0.89 (0.89) 0.75 (1.81) -0.16 (1.44) -0.14 (2.05) 0.23 (0.26) -0.53 (0.34) 15.95 (6.12)
Model(τ, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.79 (0.29) 0.59 (0.44) 0.00 — 0.00 — 0.24 (0.20) -0.50 (0.20) -0.02 (0.27)
0.22 0.79 (0.28) 0.58 (0.39) 0.00 — 0.00 — 0.21 (0.20) -0.50 (0.21) 0.22 (1.47)
0.41 0.76 (0.27) 0.58 (0.35) 0.00 — 0.00 — 0.21 (0.20) -0.51 (0.20) 0.45 (1.93)
0.69 0.79 (0.26) 0.58 (0.31) 0.00 — 0.00 — 0.22 (0.20) -0.51 (0.20) 0.72 (3.68)
1.10 0.82 (0.24) 0.59 (0.25) 0.00 — 0.00 — 0.24 (0.20) -0.51 (0.20) 1.07 (5.51)
1.61 0.83 (0.20) 0.63 (0.24) 0.00 — 0.00 — 0.26 (0.19) -0.52 (0.19) 1.54 (6.86)
∞ 0.89 (0.16) 0.66 (0.19) 0.00 — 0.00 — 0.30 (0.18) -0.50 (0.21) 4.00 (7.52)
Model(β, α)
ν τˆ0 τˆ1 βˆ0 βˆ1 αˆ0 αˆ1 νˆ0
0.00 0.00 — 0.00 — 0.89 (0.36) 0.04 (0.25) 0.19 (0.17) -0.51 (0.17) -0.34 (0.44)
0.22 0.00 — 0.00 — 0.89 (0.38) 0.07 (0.28) 0.19 (0.18) -0.50 (0.18) 0.01 (0.79)
0.41 0.00 — 0.00 — 0.92 (0.38) 0.03 (0.30) 0.19 (0.19) -0.51 (0.19) 0.24 (1.99)
0.69 0.00 — 0.00 — 1.04 (0.38) 0.06 (0.33) 0.23 (0.17) -0.51 (0.19) 0.70 (3.81)
1.10 0.00 — 0.00 — 1.21 (0.35) 0.07 (0.33) 0.29 (0.16) -0.50 (0.20) 1.27 (5.92)
1.61 0.00 — 0.00 — 1.35 (0.36) 0.09 (0.38) 0.34 (0.17) -0.50 (0.21) 2.32 (7.23)
∞ 0.00 — 0.00 — 1.66 (0.36) 0.13 (0.43) 0.42 (0.17) -0.50 (0.22) 15.98 (6.32)
All numbers are rounded to two decimal places. For the models with fixed parameters, the
“estimated” value shown is the value at which the parameter is fixed, and its standard error is
then indicated by “—”.
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